Enovis (ENOV) Change in Account Payables (2012 - 2026)
Enovis (ENOV) posted quarterly Change in Account Payables of $26.9 million for Q2 2026, up 541.85% year-over-year from $4.2 million in Q2 2025, and up 334.17% quarter-over-quarter from -$11.5 million in Q4 2025.
Enovis (ENOV) Change in Account Payables (2012 - 2026) Analysis & Trends
Enovis (ENOV) has reported Change in Account Payables for 15 consecutive years, with $26.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Account Payables rose 541.85% year-over-year to $26.9 million; the TTM figure through Apr 2026 stood at $21.6 million (down 27.95% YoY), while the FY2025 annual figure was -$1.1 million, down 108.13% from the prior year.
- Change in Account Payables advanced to $26.9 million in Q2 2026 per ENOV's latest filing, from -$11.5 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $26.9 million in Q2 2026 and bottomed at -$46.0 million in Q4 2022.
- Historically, Change in Account Payables has averaged $1.3 million across 5 years, with a median of $4.2 million in 2025.
- Annual changes were most pronounced in 2022 — Change in Account Payables plunged 232.26% — and 2026, when it soared 541.85%.
- Enovis' Change in Account Payables stood at -$46.0 million in 2022, then surged by 112.48% to $5.7 million in 2023, then surged by 343.91% to $25.5 million in 2024, then sank by 145.05% to -$11.5 million in 2025, then soared by 334.17% to $26.9 million in 2026.
- Business Quant data shows ENOV's Change in Account Payables at $26.9 million in Q2 2026, -$11.5 million in Q4 2025, and -$12.8 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Enovis | 1.51 Bn | 1.50 Bn | 359.25 Mn | -21.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | -21.91 Mn |
| Jul 3, 2026 | -21.91 Mn |
| Apr 3, 2026 | 26.89 Mn |
| Apr 3, 2026 | 26.89 Mn |
| Dec 31, 2025 | -11.48 Mn |
| Dec 31, 2025 | -11.48 Mn |
| Oct 3, 2025 | -12.82 Mn |
| Oct 3, 2025 | -12.82 Mn |
| Jul 4, 2025 | 18.97 Mn |
| Jul 4, 2025 | 18.97 Mn |
| Apr 4, 2025 | 4.19 Mn |
| Apr 4, 2025 | 4.19 Mn |
| Dec 31, 2024 | 25.49 Mn |
| Dec 31, 2024 | 25.49 Mn |
| Sep 27, 2024 | -4.76 Mn |
| Sep 27, 2024 | -4.76 Mn |
| Jun 28, 2024 | 5.01 Mn |
| Jun 28, 2024 | 5.01 Mn |
| Mar 29, 2024 | -11.75 Mn |
| Mar 29, 2024 | -11.75 Mn |